Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,243 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06427408Recruiting
Placenta Gene Study in Early and Full-Term Pregnancy
This study looks at gene activity in the placenta during early and full-term pregnancy. It may help researchers understand how the placenta works and how it affects both mother and baby.
Paris, IDFAges 18–50 - NCT06433284Recruiting
Comparing two treatments for large macular holes
This study compares two ways to repair a large macular hole: one using a hydrogel made from donated amniotic membrane (the tissue that surrounds a baby during pregnancy), and one using a small flap of your own retina. The goal is to see which approach helps the hole close better and improves vision.
Nakhon Si Thammarat, ThasalaAges 18 years+ - NCT06436937Recruiting
Testing protein from fava beans and honey chlorella in healthy adults
This study looks at how well your body uses protein from fava beans and honey chlorella. It may help find new plant-based protein sources.
BobignyAges 18–60 - NCT06439914RecruitingPhase 1
New PET scan to see immune response to lung cancer treatment
This study tests if a new type of PET scan can see changes in your immune system when you receive immunotherapy for non-small cell lung cancer. It may help doctors understand how well your treatment is working.
Detroit, MichiganAges 18 years+ - NCT06451120RecruitingPhase 2
Platelet-rich plasma injections for knee arthritis
This study tests whether platelet-rich plasma (PRP) injections can help knee arthritis in both younger and older adults. If you have knee pain from arthritis and haven't had other treatments recently, you might be able to join.
San Francisco, CaliforniaAges 18–70 - NCT06451718Recruiting
A new implant for keratoconus to avoid corneal transplant
This trial tests a small metal implant placed in the cornea to treat keratoconus, a condition where the cornea thins and bulges. The goal is to see if the implant can safely improve vision and prevent the need for a corneal transplant.
Roma, RomaAges 18 years+ - NCT06452706RecruitingPhase 2
Study of TQB2102 for HER2-negative breast cancer that has spread
This study tests a new drug, TQB2102, for people with HER2-negative breast cancer that has spread and no longer responds to standard treatments. The goal is to see if the drug can shrink tumors or slow the cancer.
Bozhou, AnhuiAges 18–75 - NCT06457438Recruiting
Hepatitis E virus in organ and cell donors
This study looks for the hepatitis E virus in samples from people who are donating organs or cells. It helps us understand how common this virus is in donors and how to keep transplants safe.
Ostrava, Moravian-Silesian RegionAges Any age - NCT06463392Recruiting
Deep learning tool to diagnose post-radiation nasopharyngeal changes
This trial tests a new computer-based tool (deep learning) to help diagnose a condition called sbORN (suspected benign or recurrent nasopharyngeal carcinoma) after radiation therapy. It aims to see if the tool can accurately tell if a suspicious spot is a recurrence or something harmless.
Guangzhou, GuangdongAges 18 years+ - NCT06467942Recruiting
Chinese medicine and probiotics for persistent HPV
This trial tests whether a combination of Chinese medicine and a probiotic (Lactobacillus) can help clear a long-lasting HPV infection. It's for women who have had the same high-risk HPV type for over a year and have not developed serious cervical changes.
Beijing, Beijing MunicipalityAges 25 years+ - NCT06474260Recruiting
A wellness program for resilient young tribal adults
This trial tests a program called 'One All' designed to support the well-being of young tribal adults. If you are a tribal adult and can speak one of the study languages, you may be able to join.
Chamrajnagar, KarnatakaAges 12–25 - NCT06554223Recruiting
HIV treatment support for people with gaps in care
This study is for people with HIV who have had a gap in care (missed an appointment or had a detectable viral load). It tests a program to help you stay on your dolutegravir-based HIV medication and keep your viral load undetectable.
Cape TownAges 18 years+ - NCT06572280Recruiting
Non-invasive nerve stimulation for ARDS patients
This trial tests a non-invasive device that stimulates the phrenic nerve (the nerve that controls your diaphragm) to help you breathe on your own sooner. It is for adults with ARDS who have been on a breathing machine for less than two days.
Nanjing, JiangsuAges Any age - NCT06549686RecruitingPhase 3
Knee osteoarthritis treatment study with cell therapy
This trial tests a new cell-based treatment (CLS2901C) for knee osteoarthritis. It combines the treatment with a realignment surgery (proximal tibial osteotomy) to help repair cartilage damage and reduce pain.
Ebina, KanagawaAges 20–79 - NCT07693244RecruitingPhase 2
Exosome therapy for male pattern baldness
This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.
BeijingAges 18–55 - NCT07220616RecruitingPhase 1/Phase 2
DS3790a for people with blood cancers
This trial tests a new drug called DS3790a for people with certain blood cancers that have not responded well to other treatments. The drug is given for the first time in humans, so researchers are checking its safety and how well it works.
New York, New YorkAges 18 years+ - NCT06486259Recruiting
Assessing lung injury risk in ventilated patients
This study looks at the risk of lung injury in patients on a ventilator who have ARDS (a severe lung inflammation). It aims to better understand how the lungs respond and to find safer breathing settings for you.
San Juan Bautista, Buenos AiresAges 18–75 - NCT06487286Recruiting
Visfatin/NAMPT levels in breast milk study
This study looks at a substance called visfatin/NAMPT in breast milk to learn more about its role in newborn health. It involves healthy full-term babies and their mothers who are in the hospital and can provide breast milk samples.
Ponderano, BIAges Any age - NCT06489782Recruiting
New approach to test alcohol use disorder medications
This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.
New Haven, ConnecticutAges 21–65 - NCT06490783Recruiting
Studying a smart technology system for healthy aging
This study tests a new technology system that uses sensors and artificial intelligence to support healthy aging. Researchers want to see if it can help older adults improve their well-being and stay healthy.
MessinaAges 60 years+ - NCT06494891RecruitingPhase 2
Understanding motivation for IV alcohol drinking
This study looks at why people with alcohol use disorder choose to drink alcohol given through an IV. The goal is to better understand the motivation behind drinking, which could help improve treatments.
Los Angeles, CaliforniaAges 21–65 - NCT06508463RecruitingPhase 1
Viral therapy for peripheral T-cell lymphoma
This study tests an experimental virus therapy given through a vein for people with a type of lymphoma called peripheral T-cell lymphoma that has come back or not responded to treatment. The virus is designed to infect and destroy cancer cells. Some patients may also receive another drug called cemiplimab as part of a combination group.
Scottsdale, ArizonaAges 18 years+ - NCT06515717Recruiting
Exogenous ketones and their effect on behavior
This study tests whether a drink containing ketone esters affects how people think and behave. It's for healthy, active adults who are not on any regular medication and have no major health conditions. You must also speak German fluently.
Potsdam, BrandenburgAges 18–45 - NCT06516601Recruiting
Severe community-acquired pneumonia observational study
This study looks at patients with severe pneumonia caught outside the hospital. Researchers will review medical records to learn more about how this serious infection progresses.
Trieste, TSAges 18 years+
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,243 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.